Impact of desmopressin on hematoma expansion in patients presenting to the emergency department on antiplatelet therapy: Don't expand study

Overview of attention for article published in American Journal of Emergency Medicine, March 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 17 X users
video: 1 YouTube creator

bluesky: 3 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 3 Bluesky posts from 3 Bluesky users, with an upper bound of 1,883 followers.

RP @meganarech.bsky.social: 🔥New EMPHARM-NET DONT EXPAND Study: 💊Propensity-matched, 11 EDs: desmopressin (n=35) vs. controls (n=140) 😷Desmo patients had higher baseline ICH volumes 🧠No difference in good or excellent hemostatic efficacy assessed via …

🔥New EMPHARM-NET DONT EXPAND Study: 💊Propensity-matched, 11 EDs: desmopressin (n=35) vs. controls (n=140) 😷Desmo patients had higher baseline ICH volumes 🧠No difference in good or excellent hemostatic efficacy assessed via hematoma volumes www.scienc…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.